FR2369M - New drug against disorders of the central nervous system. - Google Patents

New drug against disorders of the central nervous system.

Info

Publication number
FR2369M
FR2369M FR912568A FR912568A FR2369M FR 2369 M FR2369 M FR 2369M FR 912568 A FR912568 A FR 912568A FR 912568 A FR912568 A FR 912568A FR 2369 M FR2369 M FR 2369M
Authority
FR
France
Prior art keywords
nervous system
central nervous
new drug
drug against
against disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR912568A
Other languages
French (fr)
Inventor
Claude Paul Joseph Roux
Dieran Robert Torossian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jouveinal Laboratories
Original Assignee
Jouveinal Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jouveinal Laboratories filed Critical Jouveinal Laboratories
Priority to FR912568A priority Critical patent/FR2369M/en
Application granted granted Critical
Publication of FR2369M publication Critical patent/FR2369M/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR912568A 1962-10-17 1962-10-17 New drug against disorders of the central nervous system. Active FR2369M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR912568A FR2369M (en) 1962-10-17 1962-10-17 New drug against disorders of the central nervous system.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR912568A FR2369M (en) 1962-10-17 1962-10-17 New drug against disorders of the central nervous system.

Publications (1)

Publication Number Publication Date
FR2369M true FR2369M (en) 1964-03-02

Family

ID=87520232

Family Applications (1)

Application Number Title Priority Date Filing Date
FR912568A Active FR2369M (en) 1962-10-17 1962-10-17 New drug against disorders of the central nervous system.

Country Status (1)

Country Link
FR (1) FR2369M (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075241A (en) * 1971-05-12 1978-02-21 Gruppo Lepetit S.P.A. 2-(Aryl)-3-(dimethylamino)butyl-3,4,5-trimethoxybenzoates
EP0065666A1 (en) * 1981-05-21 1982-12-01 ERREGIERRE S.p.A. Salts of cholic acids, process for their preparation and therapeutic compositions containing them as active principles
EP0100983A1 (en) * 1982-08-17 1984-02-22 PROTER S.p.A. Steroid compounds with choleretic activity, a process for their preparation, and therapeutic compounds which contain them as active principle
FR2690917A1 (en) * 1992-05-05 1993-11-12 Jouveinal Inst Rech New amino-di:chloro-benzyl-propanol ester cpds. - used to treat depression, neuroses, mood disturbance, migraine, insomnia and nausea

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075241A (en) * 1971-05-12 1978-02-21 Gruppo Lepetit S.P.A. 2-(Aryl)-3-(dimethylamino)butyl-3,4,5-trimethoxybenzoates
EP0065666A1 (en) * 1981-05-21 1982-12-01 ERREGIERRE S.p.A. Salts of cholic acids, process for their preparation and therapeutic compositions containing them as active principles
EP0100983A1 (en) * 1982-08-17 1984-02-22 PROTER S.p.A. Steroid compounds with choleretic activity, a process for their preparation, and therapeutic compounds which contain them as active principle
FR2690917A1 (en) * 1992-05-05 1993-11-12 Jouveinal Inst Rech New amino-di:chloro-benzyl-propanol ester cpds. - used to treat depression, neuroses, mood disturbance, migraine, insomnia and nausea

Similar Documents

Publication Publication Date Title
FI50707C (en) Process for the preparation of new pharmacologically active hydroxycyclohexylamines.
FI46071C (en) A process for the preparation of 1-substituted-5-nitroimidazol-2-ylalkyl carbamate for the treatment of parasitic diseases.
FR2369M (en) New drug against disorders of the central nervous system.
FR3056M (en) New drug for liver ailments.
FR2852M (en) Pharmaceutical preparations acting on the central nervous system.
FI48578C (en) Process for the preparation of diarylcyclopropane derivatives stimulating the central nervous system.
FI51175C (en) Process for the preparation of indanylthiocarbamates for therapeutic use.
FR3361M (en) New anthelmintic drug.
FR1626M (en) New drug for the stimulation of the central nervous system.
BE633950A (en) Corrective medication for metabolic disorders.
FR2193M (en) New drug for the treatment of infectious diseases.
IT998001B (en) PROCEDURE FOR THE PRODUCTION OF HYGIENIC ABSORBENTS
FR2370M (en) New drug for the treatment of disorders of the central nervous system.
FR1347M (en) Injectable drug for mental disorders.
FR2033M (en) New drug acting on the central nervous system.
FR2400M (en) New neuro-trophic and anti-anemic analgesic drug.
FR3500M (en) New drug for the treatment of rhinitis.
BE633949A (en) Corrective medication for metabolic disorders.
FR40F (en) New drug for oral diseases.
FR3221M (en) New synthetic drug for the treatment of neuro-psychic disorders.
BE618277R (en) Injectable drug for mental disorders.
FR1669M (en) New bacteriostatic drug.
AU269490B2 (en) New pharmaceutical compounds
FR1911M (en) New drug for the treatment of disorders of the circulatory system.
FR1828M (en) Spasmolytic drug.